.jpg)
![The breaking news round-up: Decagear launches today, Pimax announces new headsets, and more! [APRIL FOOL’S]](https://i0.wp.com/skarredghost.com/wp-content/uploads/2025/03/lawk_glasses_handson.jpg?fit=1366%2C1025&ssl=1)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
At the end of Robert F. Kennedy Jr.'s confirmation hearing, Senate HELP Committe...
GRO Biosciences, a small but ambitious biotech startup attempting to create nove...
A Seattle biotech trying to take on one of the world’s biggest vaccines has nabb...
A small Swiss drug developer is being scooped up for its pipeline of three antib...
AstraZeneca is fine-tuning plans for a Phase 3 study for its B7-H4-targeting ADC...
A Boston biotech trying to bring transfer RNA (tRNA) biology to the drug develop...
Avidity Biosciences shared Monday that its RNA drug for people with certain muta...
AstraZeneca said Monday that it has agreed to acquire a cell therapy biotech fou...
Latigo Biotherapeutics thinks it can one-up Vertex Pharmaceuticals' recently app...
Maxion Therapeutics has secured $72 million in an oversubscribed Series A raise,...
Welcome back to Endpoints Weekly. Our reporters tracked a flurry of deals and da...
Mehmet Oz has committed to defending Medicare drug price negotiations in court i...
The US Court of Appeals for the Federal Circuit on Friday ruled against Regenero...
The once-fledgling field of MASH drug developers is now one of the few areas of ...
The UK government is planning to double the proportion of money drugmakers have ...
Greg Behar’s shakeup of Recipharm is paying off in his first year as CEO. Th...